Myelodysplastic Syndrome with Excess Blasts
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome with Excess Blasts.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic Leukemia and Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm [Phase 2]
Clinical trial update of a Phase 2 study evaluating venetoclax in combination with ASTX727 (oral decitabine/cedazuridine) for chronic myelom…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes With Increased Blasts [Phase 1]
Phase 1 clinical trial evaluating TAK-243 for relapsed or refractory acute myeloid leukemia and myelodysplastic syndromes with increased bla…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts [Phase 1]
Phase 1 study evaluating talazoparib for cohesin-mutated acute myeloid leukemia and myelodysplastic syndrome with excess blasts; the trial i…